F

Forte Biosciences
D

FBRX

16.300
USD
0.10
(0.62%)
Market Open
Volume
1,440
EPS
-20
Div Yield
-
P/E
-1
Market Cap
23,829,524
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    ABBV
    -4.630
    (-2.73%)
    179.230 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    267.42 USD
    AZN
    AZN
    -1.830
    (-2.81%)
    66.210 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    797.06 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    100.585 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.740 USD
    SNY
    SNY
    0.160
    (0.33%)
    47.960 USD
    More
News

Title: Forte Biosciences Inc

Sector: Healthcare
Industry: Biotechnology
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indicationsas graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).